Suboxone end-payor antitrust settlement with Indivior
In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (End Payor settlement with Indivior)
Also known as Reckitt Benckiser; Suboxone antitrust; MDL 2445; SuboxAntitrust
The lawsuit claimed Indivior harmed competition, so buyers paid too much for Suboxone.
Copied from the official notice. Last compared Nov 7, 2026.
- You could get
- A share of the fund $30 million fund, split among everyone who files.
Source
“Pro rata share of a $30 million fund”
From the administrator site: Long Form Notice (court-approved, August 2023, on the settlement site). Last compared Nov 7, 2026.
- Payments
- Paid Payments went out Apr 27, 2026. Has it paid yet? See payment status.
Source
“Distribution checks were mailed to eligible claimants on April 27, 2026. Authorized eligible claimants were paid their portion of the Net Settlement Fund based on a number of components outlined in the Plan of Allocation, which can be found under the Court Documents tab above.”
From the administrator site: Official settlement site home page (A.B. Data). Last compared Nov 7, 2026.
- Claims
- Closed Feb 17, 2024
Source
“Claim Forms must be postmarked (if mailed) or received (if submitted online) on or before February 17, 2024.”
From the administrator site: Official settlement site home page (A.B. Data). Last compared Nov 7, 2026.
- Who can file
- Paid for Suboxone or its generic, Dec 2011 to Aug 2023
Source
“The following persons or entities are excluded from the End Payor Class: (i) Pharmacy benefit managers; (ii) Defendant and its officers, directors, management, employees, subsidiaries, or affiliates; (iii) all governmental entities, except for government funded employee benefit plans; (iv) all persons or entities who purchased Suboxone or its AB-rated generic equivalents in any form for purposes of resale or directly from Defendant or its affiliates; and (v) the judges in this case and any members of their immediate families.”
From the court record: Order granting final approval of End Payor settlement, E.D. Pa. MDL 2445, Doc. 991 (filed 12/04/23; copy on the settlement site). Last compared Nov 7, 2026.
- Where
- 48 states, D.C. and Puerto Rico: check yours
Source
“All persons or entities who purchased and/or paid for some or all of the purchase price for Co-Formulated Buprenorphine/Naloxone (Suboxone and/or its AB-rated generic equivalent) in any form, for consumption by themselves, their families or their members, employees, plan participants, beneficiaries or insureds in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and District of Columbia between December 22, 2011 and August 21, 2023.”
From the administrator site: Official settlement site home page (A.B. Data). Last compared Nov 7, 2026.
Quick answers
How much is the Suboxone end-payor antitrust settlement with Indivior payout?
A share of the fund. $30 million fund, split among everyone who files.
Can I still file a claim for the Suboxone end-payor antitrust settlement with Indivior?
No. Claims closed on Feb 17, 2024.
When is the Suboxone end-payor antitrust settlement with Indivior payout date?
Payments went out Apr 27, 2026.
Is the Suboxone end-payor antitrust settlement with Indivior legit?
The settlement administrator (the company that handles claims) is A.B. Data, and the official site is www.suboxantitrust.com. Real notices point there; if a link in a message goes anywhere else, do not use it.
The official site never asks you to pay to file.
Also ending this week
Related settlements
Confirm with the administrator before you act.
Case details
- Case
- In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (End Payor settlement with Indivior)
- Court
- U.S. District Court, Eastern District of Pennsylvania
- Case number
- 2:13-md-02445-MSG
- Administrator
- A.B. Data
- Official site
- www.suboxantitrust.com
- Settlement fund
- $30 million
- Full payout terms
- Pro rata share of a $30 million fundPro rata share of the Net Settlement Fund ($30 million less fees, costs and awards), based on the amount paid; consumers get 45% of each state pool and third-party payors 55%.
- States
- Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, District of Columbia
Other dates
- Objection deadline
- (passed) source document
- Opt-out (exclusion) deadline
- (passed) source document
- Final approval hearing
- (passed) source document
- Final approval granted
- From the court order we read.From the court's signed Order granting final approval (Doc. 991, filed December 4, 2023), read on the copy posted on the settlement site. The court authorized distribution of the fund by a separate order on March 18, 2026. Source: court record
- Distribution order
- source document
- Payments issued
- source document
The court’s exact words
All persons or entities who purchased and/or paid for some or all of the purchase price for Co-Formulated Buprenorphine/Naloxone (Suboxone and/or its AB-rated generic equivalent) in any form, for consumption by themselves, their families or their members, employees, plan participants, beneficiaries or insureds in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and District of Columbia between December 22, 2011 and August 21, 2023.
Quoted from the official notice. Read the notice for the full definition.
You may be included if you paid all or part of the price of Suboxone or generic Suboxone from December 22, 2011 to August 21, 2023.
It covers purchases in a listed state, D.C. or Puerto Rico (all states but Indiana and Ohio), not for resale or direct from Indivior.
You are not included if you are a PBM, Indivior or an affiliate, a government entity (not an employee plan), or a judge or their family.
Sources and checks (6)
Every fact people act on was copied from the official source and compared with it. How we check
- Official settlement site home page (A.B. Data) administrator site
- Official site Contact Information page administrator site
- Order granting final approval of End Payor settlement, E.D. Pa. MDL 2445, Doc. 991 (filed 12/04/23; copy on the settlement site) court record
- Order authorizing distribution of the Net Settlement Fund, E.D. Pa. 13-md-2445, Doc. 1039 (filed 03/18/26; copy on the settlement site) court record
- Long Form Notice (court-approved, August 2023, on the settlement site) administrator site
- Plan of Allocation (updated 9-26-2023, on the settlement site) administrator site
What changedLast change Nov 4, 2026
- Payment-status page created. The court granted final approval on December 4, 2023 and authorized distribution on March 18, 2026; the administrator's site says distribution checks were mailed to eligible claimants on April 27, 2026. source document
Questions
I already filed. What now?
If your claim was filed on time and accepted, it is in the pool. The administrator pays, usually after final approval and any appeals. Contact the administrator with your claim ID if something looks wrong. Never pay anyone to check on a claim.